Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines

Bibliographic Details
Main Authors:	Desh Deepak Singh, Amna Parveen, Dharmendra Kumar Yadav
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	SARS-CoV-2 variant vaccine neutralization infectivity
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.885482/full

Similar Items

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
by: Desh Deepak Singh, et al.
Published: (2021-12-01)

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
by: Desh Deepak Singh, et al.
Published: (2022-02-01)

A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
by: Desh Deepak Singh, et al.
Published: (2023-01-01)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
by: Gabriele Anichini, et al.
Published: (2021-05-01)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021-10-01)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
by: Ailan Xu, et al.
Published: (2022-09-01)

The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants
by: Hui Xie, et al.
Published: (2024-07-01)

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH
by: Alessandra Vergori, et al.
Published: (2022-08-01)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)

Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
by: Tulio J. Lopera, et al.
Published: (2022-05-01)

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
by: Jianglong Li, et al.
Published: (2022-10-01)

COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants
by: Paola Stefanelli, et al.
Published: (2022-06-01)

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
by: Daniel Martínez-Flores, et al.
Published: (2021-07-01)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
by: Ju-yeon Choi, et al.
Published: (2022-07-01)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
by: Fuxing Lou, et al.
Published: (2021-11-01)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022-03-01)

Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
by: Jianzhong Zhang, et al.
Published: (2023-01-01)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
by: Stephane Marot, et al.
Published: (2022-12-01)

Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
by: Han Di, et al.
Published: (2024-05-01)

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
by: Palmira Immordino, et al.
Published: (2023-11-01)

Humoral Response Kinetics and Cross-Immunity in Hospitalized Patients with SARS-CoV-2 WT, Delta, or Omicron Infections: A Comparison between Vaccinated and Unvaccinated Cohorts
by: Hyunhye Kang, et al.
Published: (2023-12-01)

A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
by: Olaf-Oliver Wolz, et al.
Published: (2022-03-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
by: Florian D. Hastert, et al.
Published: (2022-05-01)

Re-Evaluation and Retrospective Comparison of Serum Neutralization Induced by Three Different Types of Inactivated SARS-CoV-2 Vaccines
by: Weiyu Jiang, et al.
Published: (2024-10-01)

Sputnik V-Induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela
by: Christopher Franco, et al.
Published: (2024-09-01)

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
by: Sindhu Ramesh, et al.
Published: (2021-10-01)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022-11-01)

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice
by: Shuo Song, et al.
Published: (2022-01-01)

SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
by: Yifei Guo, et al.
Published: (2022-04-01)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
by: Varghese Edwin Hillary, et al.
Published: (2023-03-01)

Investigation of SARS-CoV-2 Variants and Their Effect on SARS-CoV-2 Monoclonal Antibodies, Convalescent and Vaccine Plasma by a Novel Web Tool
by: Ayse Arikan, et al.
Published: (2022-11-01)

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R
by: Orna Mor, et al.
Published: (2021-08-01)

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
by: Xiao-Feng Li, et al.
Published: (2022-11-01)

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
by: Doreen Lugano, et al.
Published: (2024-12-01)

Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
by: Kristin Widyasari, et al.
Published: (2023-08-01)

Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants
by: Chun-Hsiang Chiu, et al.
Published: (2022-10-01)

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
by: Renuka Raman, et al.
Published: (2021-07-01)

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
by: Ahlam Chaqroun, et al.
Published: (2021-06-01)